These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33836929)

  • 1. Evolutionary constraints on the acquisition of antimicrobial peptide resistance in bacterial pathogens.
    Jangir PK; Ogunlana L; MacLean RC
    Trends Microbiol; 2021 Dec; 29(12):1058-1061. PubMed ID: 33836929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Peptide Combination Can Hinder Resistance Evolution.
    Maron B; Rolff J; Friedman J; Hayouka Z
    Microbiol Spectr; 2022 Aug; 10(4):e0097322. PubMed ID: 35862981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial peptides: Sustainable application informed by evolutionary constraints.
    Chen X; Han J; Cai X; Wang S
    Biotechnol Adv; 2022 Nov; 60():108012. PubMed ID: 35752270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections.
    Zhu Y; Hao W; Wang X; Ouyang J; Deng X; Yu H; Wang Y
    Med Res Rev; 2022 Jul; 42(4):1377-1422. PubMed ID: 34984699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial peptides for combating drug-resistant bacterial infections.
    Xuan J; Feng W; Wang J; Wang R; Zhang B; Bo L; Chen ZS; Yang H; Sun L
    Drug Resist Updat; 2023 May; 68():100954. PubMed ID: 36905712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and advances in antimicrobial peptide development.
    Botelho Sampaio de Oliveira K; Lopes Leite M; Albuquerque Cunha V; Brito da Cunha N; Luiz Franco O
    Drug Discov Today; 2023 Aug; 28(8):103629. PubMed ID: 37230283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections.
    Askari P; Yousefi M; Foadoddini M; Neshani A; Aganj M; Lotfi N; Movaqar A; Ghazvini K; Namaei MH
    Curr Microbiol; 2022 Feb; 79(4):102. PubMed ID: 35152319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in antimicrobial peptide-based therapy.
    Mulukutla A; Shreshtha R; Kumar Deb V; Chatterjee P; Jain U; Chauhan N
    Bioorg Chem; 2024 Apr; 145():107151. PubMed ID: 38359706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Peptides: the Achilles' Heel of Antibiotic Resistance?
    Lewies A; Du Plessis LH; Wentzel JF
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):370-381. PubMed ID: 30229514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptides: features, applications and the potential use against covid-19.
    Mabrouk DM
    Mol Biol Rep; 2022 Oct; 49(10):10039-10050. PubMed ID: 35606604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria.
    Moravej H; Moravej Z; Yazdanparast M; Heiat M; Mirhosseini A; Moosazadeh Moghaddam M; Mirnejad R
    Microb Drug Resist; 2018; 24(6):747-767. PubMed ID: 29957118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial peptides - Unleashing their therapeutic potential using nanotechnology.
    Gera S; Kankuri E; Kogermann K
    Pharmacol Ther; 2022 Apr; 232():107990. PubMed ID: 34592202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial peptides: Opportunities and challenges in overcoming resistance.
    Bucataru C; Ciobanasu C
    Microbiol Res; 2024 Sep; 286():127822. PubMed ID: 38986182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Peptides Therapy: An Emerging Alternative for Treating Drug-Resistant Bacteria.
    Mba IE; Nweze EI
    Yale J Biol Med; 2022 Dec; 95(4):445-463. PubMed ID: 36568838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the arsenal of antimicrobial peptides: Mechanisms, diversity, and applications.
    Savitskaya A; Masso-Silva J; Haddaoui I; Enany S
    Biochimie; 2023 Nov; 214(Pt B):216-227. PubMed ID: 37499896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for improving antimicrobial peptide production.
    Deo S; Turton KL; Kainth T; Kumar A; Wieden HJ
    Biotechnol Adv; 2022 Oct; 59():107968. PubMed ID: 35489657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No country for old antibiotics! Antimicrobial peptides (AMPs) as next-generation treatment for skin and soft tissue infection.
    Răileanu M; Borlan R; Campu A; Janosi L; Turcu I; Focsan M; Bacalum M
    Int J Pharm; 2023 Jul; 642():123169. PubMed ID: 37356506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Peptide Exposure Selects for Resistant and Fit Stenotrophomonas maltophilia Mutants That Show Cross-Resistance to Antibiotics.
    Blanco P; Hjort K; Martínez JL; Andersson DI
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32999081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the design of antimicrobial peptide conjugates.
    Silva ARP; Guimarães MS; Rabelo J; Belén LH; Perecin CJ; Farías JG; Santos JHPM; Rangel-Yagui CO
    J Mater Chem B; 2022 May; 10(19):3587-3600. PubMed ID: 35262120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics.
    Yu G; Baeder DY; Regoes RR; Rolff J
    Proc Biol Sci; 2018 Mar; 285(1874):. PubMed ID: 29540517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.